Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 74,121 |
|
|||||
| News | - | ||||||
| Day High | 10.86 | Low High |
|||||
| Day Low | 10.55 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.22 | 2.08% | 10.82 | 13:46:12 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 10.59 | 10.55 | 10.86 | 10.60 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,478 | 74,121 | $ 10.76 | $ 797,782 | - | 8.20 - 18.24 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:45:52 | 100 | $ 10.82 | USD |
iTeos Therapeutics (ITOS) Options Flow Summary
iTeos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 389.26M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
iTeos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.27 | 11.22 | 10.01 | 10.66 | 348,619 | 0.55 | 5.36% |
| 1 Month | 13.80 | 13.80 | 10.01 | 11.82 | 276,468 | -2.98 | -21.59% |
| 3 Months | 10.04 | 13.80 | 9.70 | 11.34 | 288,477 | 0.78 | 7.77% |
| 6 Months | 9.35 | 13.80 | 8.7301 | 10.77 | 301,390 | 1.47 | 15.72% |
| 1 Year | 13.41 | 18.24 | 8.20 | 11.77 | 361,247 | -2.59 | -19.31% |
| 3 Years | 24.03 | 52.43 | 8.20 | 21.49 | 364,003 | -13.21 | -54.97% |
| 5 Years | 19.70 | 52.43 | 8.20 | 22.63 | 332,584 | -8.88 | -45.08% |
iTeos Therapeutics Description
| ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |
